{"id":234,"date":"2013-10-31T11:14:32","date_gmt":"2013-10-31T10:14:32","guid":{"rendered":"https:\/\/www.farmaindustria.es\/web\/?p=234"},"modified":"2014-01-03T11:53:40","modified_gmt":"2014-01-03T10:53:40","slug":"la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit","status":"publish","type":"post","link":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/","title":{"rendered":"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit"},"content":{"rendered":"<p>Por primera vez, la balanza comercial del sector farmac\u00e9utico espa\u00f1ol se acerca al equilibrio y se encuentra a punto de entrar en super\u00e1vit, seg\u00fan refleja el \u00faltimo <em>Bolet\u00edn de Coyuntura del Mercado del Medicamento en Espa\u00f1a<\/em> que elabora mensualmente Farmaindustria, a partir de datos de la Secretar\u00eda de Estado de Comercio, correspondientes al periodo enero-julio de 2013.<\/p>\n<p>As\u00ed, entre enero y julio de 2013 las exportaciones de medicamentos alcanzaron los 6.100 millones de euros (un 21% m\u00e1s que en el mismo periodo de 2012) mientras que las importaciones se elevan hasta los 6.228 millones (s\u00f3lo un 4% m\u00e1s que en dicho periodo del a\u00f1o pasado). Esto supondr\u00eda que la balanza comercial farmac\u00e9utica espa\u00f1ola en los primeros siete meses del a\u00f1o habr\u00eda registrado una tasa de cobertura del 98%.<\/p>\n<p>Tradicionalmente, y a pesar de que la industria farmac\u00e9utica espa\u00f1ola tiene una gran vocaci\u00f3n exportadora, las peculiares caracter\u00edsticas de la producci\u00f3n de medicamentos (muy globalizada y concentrada en grandes centros de fabricaci\u00f3n) provocaban que las importaciones de f\u00e1rmacos fueran superiores a las exportaciones espa\u00f1olas en este \u00e1mbito, lo que supon\u00eda una balanza comercial farmac\u00e9utica deficitaria.<\/p>\n<p>Sin embargo, la tasa de cobertura del comercio exterior del sector (exportaciones divididas entre importaciones) ha ido mejorando considerablemente en los \u00faltimos seis a\u00f1os, hasta situarse en el 98% en julio de este a\u00f1o. Estos datos marcan una tendencia que, de mantenerse en la \u00faltima parte del a\u00f1o, provocar\u00edan que por primera vez la balanza comercial farmac\u00e9utica de Espa\u00f1a registrara super\u00e1vit en 2013, alcanz\u00e1ndose unas exportaciones r\u00e9cord superiores a los 10.000 millones de euros.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-1923\" alt=\"Tasadecoberturadelcomercioespanol\" src=\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol.png\" width=\"655\" height=\"337\" srcset=\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol.png 655w, https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol-300x154.png 300w, https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol-50x25.png 50w\" sizes=\"auto, (max-width: 655px) 100vw, 655px\" \/><br \/>\nEl n\u00famero 101 del <em>Bolet\u00edn de Coyuntura del Mercado del Medicamento en Espa\u00f1a<\/em> est\u00e1 disponible en http:\/\/prensa.farmaindustria.es<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Por primera vez, la balanza comercial del sector farmac\u00e9utico espa\u00f1ol se acerca al equilibrio y se encuentra a punto de entrar en super\u00e1vit, seg\u00fan refleja el \u00faltimo Bolet\u00edn de Coyuntura del Mercado del Medicamento en Espa\u00f1a que elabora mensualmente Farmaindustria, a partir de datos de la Secretar\u00eda de Estado de Comercio, correspondientes al periodo enero-julio  <a href=\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\" class=\"read-more\">&hellip;<\/a><\/p>\n","protected":false},"author":2,"featured_media":1924,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-234","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","tema-distribucion","tema-medicamentos"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit - FarmaIndustria<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit - FarmaIndustria\" \/>\n<meta property=\"og:description\" content=\"Por primera vez, la balanza comercial del sector farmac\u00e9utico espa\u00f1ol se acerca al equilibrio y se encuentra a punto de entrar en super\u00e1vit, seg\u00fan refleja el \u00faltimo Bolet\u00edn de Coyuntura del Mercado del Medicamento en Espa\u00f1a que elabora mensualmente Farmaindustria, a partir de datos de la Secretar\u00eda de Estado de Comercio, correspondientes al periodo enero-julio &hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\" \/>\n<meta property=\"og:site_name\" content=\"FarmaIndustria\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-31T10:14:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2014-01-03T10:53:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"655\" \/>\n\t<meta property=\"og:image:height\" content=\"301\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Maria Moya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:site\" content=\"@FarmaIndustria\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Maria Moya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\"},\"author\":{\"name\":\"Maria Moya\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/#\/schema\/person\/4616b111eeb8a2c7e6efc5cde4a0ffd3\"},\"headline\":\"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit\",\"datePublished\":\"2013-10-31T10:14:32+00:00\",\"dateModified\":\"2014-01-03T10:53:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\"},\"wordCount\":317,\"image\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png\",\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\",\"url\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\",\"name\":\"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit - FarmaIndustria\",\"isPartOf\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png\",\"datePublished\":\"2013-10-31T10:14:32+00:00\",\"dateModified\":\"2014-01-03T10:53:40+00:00\",\"author\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/#\/schema\/person\/4616b111eeb8a2c7e6efc5cde4a0ffd3\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage\",\"url\":\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png\",\"contentUrl\":\"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png\",\"width\":655,\"height\":301},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/www.farmaindustria.es\/web\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/#website\",\"url\":\"https:\/\/www.farmaindustria.es\/web\/\",\"name\":\"FarmaIndustria\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.farmaindustria.es\/web\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.farmaindustria.es\/web\/#\/schema\/person\/4616b111eeb8a2c7e6efc5cde4a0ffd3\",\"name\":\"Maria Moya\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/7ff5c8eab0e0424184d44969f2c4d1550690651df6e3bc13dad7c324c57656ad?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7ff5c8eab0e0424184d44969f2c4d1550690651df6e3bc13dad7c324c57656ad?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7ff5c8eab0e0424184d44969f2c4d1550690651df6e3bc13dad7c324c57656ad?s=96&d=mm&r=g\",\"caption\":\"Maria Moya\"},\"url\":\"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/author\/mariamoya\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit - FarmaIndustria","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/","og_locale":"es_ES","og_type":"article","og_title":"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit - FarmaIndustria","og_description":"Por primera vez, la balanza comercial del sector farmac\u00e9utico espa\u00f1ol se acerca al equilibrio y se encuentra a punto de entrar en super\u00e1vit, seg\u00fan refleja el \u00faltimo Bolet\u00edn de Coyuntura del Mercado del Medicamento en Espa\u00f1a que elabora mensualmente Farmaindustria, a partir de datos de la Secretar\u00eda de Estado de Comercio, correspondientes al periodo enero-julio &hellip;","og_url":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/","og_site_name":"FarmaIndustria","article_publisher":"https:\/\/www.facebook.com\/pages\/Farmaindustria\/730634013647836?ref=hl","article_published_time":"2013-10-31T10:14:32+00:00","article_modified_time":"2014-01-03T10:53:40+00:00","og_image":[{"width":655,"height":301,"url":"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png","type":"image\/png"}],"author":"Maria Moya","twitter_card":"summary_large_image","twitter_creator":"@FarmaIndustria","twitter_site":"@FarmaIndustria","twitter_misc":{"Escrito por":"Maria Moya","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#article","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/"},"author":{"name":"Maria Moya","@id":"https:\/\/www.farmaindustria.es\/web\/#\/schema\/person\/4616b111eeb8a2c7e6efc5cde4a0ffd3"},"headline":"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit","datePublished":"2013-10-31T10:14:32+00:00","dateModified":"2014-01-03T10:53:40+00:00","mainEntityOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/"},"wordCount":317,"image":{"@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png","inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/","url":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/","name":"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit - FarmaIndustria","isPartOf":{"@id":"https:\/\/www.farmaindustria.es\/web\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage"},"image":{"@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png","datePublished":"2013-10-31T10:14:32+00:00","dateModified":"2014-01-03T10:53:40+00:00","author":{"@id":"https:\/\/www.farmaindustria.es\/web\/#\/schema\/person\/4616b111eeb8a2c7e6efc5cde4a0ffd3"},"breadcrumb":{"@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#primaryimage","url":"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png","contentUrl":"https:\/\/www.farmaindustria.es\/web\/wp-content\/uploads\/sites\/2\/2014\/01\/Tasadecoberturadelcomercioespanol1.png","width":655,"height":301},{"@type":"BreadcrumbList","@id":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/2013\/10\/31\/la-balanza-comercial-farmaceutica-espanola-a-punto-de-entrar-en-superavit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.farmaindustria.es\/web\/"},{"@type":"ListItem","position":2,"name":"La balanza comercial farmac\u00e9utica espa\u00f1ola, a punto de entrar en super\u00e1vit"}]},{"@type":"WebSite","@id":"https:\/\/www.farmaindustria.es\/web\/#website","url":"https:\/\/www.farmaindustria.es\/web\/","name":"FarmaIndustria","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.farmaindustria.es\/web\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.farmaindustria.es\/web\/#\/schema\/person\/4616b111eeb8a2c7e6efc5cde4a0ffd3","name":"Maria Moya","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/7ff5c8eab0e0424184d44969f2c4d1550690651df6e3bc13dad7c324c57656ad?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7ff5c8eab0e0424184d44969f2c4d1550690651df6e3bc13dad7c324c57656ad?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7ff5c8eab0e0424184d44969f2c4d1550690651df6e3bc13dad7c324c57656ad?s=96&d=mm&r=g","caption":"Maria Moya"},"url":"https:\/\/www.farmaindustria.es\/web\/prensa\/notas-de-prensa\/author\/mariamoya\/"}]}},"_links":{"self":[{"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/posts\/234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/comments?post=234"}],"version-history":[{"count":3,"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/posts\/234\/revisions"}],"predecessor-version":[{"id":1927,"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/posts\/234\/revisions\/1927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/media\/1924"}],"wp:attachment":[{"href":"https:\/\/www.farmaindustria.es\/web\/wp-json\/wp\/v2\/media?parent=234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}